Guidelines for the screening, care and treatment of persons with hepatitis C infection
WHO has just published its updated version of the guidelines for the screening, care and treatment of persons with hepatitis C infection complement existing guidance on the prevention of transmission of bloodborne viruses, including HCV. They are intended for policy-makers, government officials, and others working in low- and middle-income countries who are developing programmes for the screening, care and treatment of persons with HCV infection.
CDC’s Division of Healthcare Quality Promotion (DHQP) has a new Request For Proposals available on FedBiz Opps titled “Safe Healthcare, Epidemiology, and Prevention Research Development (SHEPheRD)”. This funding opportunity will allow CDC to continue its ability to address questions related to healthcare epidemiology and healthcare-associated infection (HAI) prevention research, including antimicrobial resistance, and also extend this work into diverse health care settings.
Chlorhexidine Tolerance Genes and Nosocomial Infections
A recent study evaluating nosocomial Staphylococcus aureus isolates for the presence of genes associated with chlorhexidine tolerance found that 45% of isolates carried one or more genes, and that strains carrying these tolerance genes were associated with reduced susceptibility to systemic antimicrobial agents and increased rates of bloodstream infections.